Literature DB >> 22833571

Health economic decision-making: a comparison between UK and Spain.

Belén Corbacho1, Jose Luis Pinto-Prades.   

Abstract

OBJECTIVE: This review examines the impact of economic evaluation in informing national or local policies within both jurisdictions. We focus on the factors that have made the economic evaluation evolves differently in both settings. AREAS OF AGREEMENT: Economic evaluation facilitates decision-making regarding the efficiency of interventions. The existence of national or local bodies regulating the process has contributed to increasing its use in decision-making and the development of its methods. AREAS OF CONTROVERSY: Cost-effectiveness approach is based on the assumption of health maximization subject to a budget constraint. Decision-makers are not only interested in health maximization alone. This may result in policy-makers failing to consider economic evaluations into their allocation decisions. AREAS TO DEVELOP RESEARCH: Methods that incorporate wider decision-makers goals (mainly local) and research to study the real impact of economic evaluation in terms of improved efficiency and equity are particularly required.

Mesh:

Year:  2012        PMID: 22833571     DOI: 10.1093/bmb/lds017

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  4 in total

1.  Emotions and scope effects in the monetary valuation of health.

Authors:  María V Avilés Blanco; Raúl Brey; Jorge Araña; José Luis Pinto Prades
Journal:  Eur J Health Econ       Date:  2017-03-24

2.  Does the approach to economic evaluation in health care depend on culture, values, and institutional context?

Authors:  Aleksandra Torbica; Rosanna Tarricone; Michael Drummond
Journal:  Eur J Health Econ       Date:  2018-07

Review 3.  Immuno-Oncology Medicines: Policy Implications and Economic Considerations.

Authors:  Georges Adunlin; Stefanie P Ferreri; Jenny Dong; Maisha Kelly Freeman
Journal:  Innov Pharm       Date:  2019-08-08

Review 4.  Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries.

Authors:  Aris Angelis; Ansgar Lange; Panos Kanavos
Journal:  Eur J Health Econ       Date:  2017-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.